Galiger C, Zohora F, Dorneburg C, Tews D, Debatin K, Beltinger C
BMC Cancer. 2023; 23(1):1148.
PMID: 38007466
PMC: 10676583.
DOI: 10.1186/s12885-023-11635-2.
Wang H, Wang X, Xu L
Ital J Pediatr. 2023; 49(1):145.
PMID: 37904225
PMC: 10617224.
DOI: 10.1186/s13052-023-01549-x.
Ren J, Fu Z, Zhao Y
Front Oncol. 2023; 13:1099290.
PMID: 37035169
PMC: 10079884.
DOI: 10.3389/fonc.2023.1099290.
Xu L, Shao F, Luo T, Li Q, Tan D, Tan Y
Int J Mol Sci. 2022; 23(15).
PMID: 35955624
PMC: 9369136.
DOI: 10.3390/ijms23158489.
Heidari Z, Asemi-Rad A, Moudi B, Mahmoudzadeh-Sagheb H
J Int Med Res. 2022; 50(7):3000605221105344.
PMID: 35808817
PMC: 9274423.
DOI: 10.1177/03000605221105344.
Mutations of 1p genes do not consistently abrogate tumor suppressor functions in 1p-intact neuroblastoma.
Kuick C, Tan J, Jasmine D, Sumanty T, Ng A, Venkatesh B
BMC Cancer. 2022; 22(1):717.
PMID: 35768791
PMC: 9245282.
DOI: 10.1186/s12885-022-09800-0.
The TAZ-CAMTA1 Fusion Protein Promotes Tumorigenesis via Connective Tissue Growth Factor and Ras-MAPK Signaling in Epithelioid Hemangioendothelioma.
Ma S, Kanai R, Pobbati A, Li S, Che K, Seavey C
Clin Cancer Res. 2022; 28(14):3116-3126.
PMID: 35443056
PMC: 9306355.
DOI: 10.1158/1078-0432.CCR-22-0421.
CHD5 inhibits metastasis of neuroblastoma.
Laut A, Dorneburg C, Furstberger A, Barth T, Kestler H, Debatin K
Oncogene. 2021; 41(5):622-633.
PMID: 34789839
PMC: 8799470.
DOI: 10.1038/s41388-021-02081-0.
Establishment and Validation of a Prognostic Immune Signature in Neuroblastoma.
Yu Y, Zeng Y, Xia X, Zhou J, Cao F
Cancer Control. 2021; 28:10732748211033751.
PMID: 34569303
PMC: 8477712.
DOI: 10.1177/10732748211033751.
ARID1A loss in neuroblastoma promotes the adrenergic-to-mesenchymal transition by regulating enhancer-mediated gene expression.
Shi H, Tao T, Abraham B, Durbin A, Zimmerman M, Kadoch C
Sci Adv. 2020; 6(29):eaaz3440.
PMID: 32832616
PMC: 7439613.
DOI: 10.1126/sciadv.aaz3440.
An overview of neuroblastoma cell lineage phenotypes and models.
Campos Cogo S, Gradowski Farias da Costa do Nascimento T, de Almeida Brehm Pinhatti F, de Franca Junior N, Santos Rodrigues B, Cavalli L
Exp Biol Med (Maywood). 2020; 245(18):1637-1647.
PMID: 32787463
PMC: 7802384.
DOI: 10.1177/1535370220949237.
Clinical significance of chromatin remodeling factor CHD5 expression in gastric cancer.
Hashimoto T, Kurokawa Y, Wada N, Takahashi T, Miyazaki Y, Tanaka K
Oncol Lett. 2020; 19(1):1066-1073.
PMID: 31897220
PMC: 6924149.
DOI: 10.3892/ol.2019.11138.
Exome sequencing identifies a novel nonsense mutation of Ring Finger Protein 207 in a Chinese family with Long QT syndrome and syncope.
Fan L, Chen Y, Huang H, Yuan Z, Jin J, Hu M
J Hum Genet. 2018; 64(3):233-238.
PMID: 30542207
DOI: 10.1038/s10038-018-0549-1.
Whole exome sequencing identified sixty-five coding mutations in four neuroblastoma tumors.
Miller A, Garcia P, Pressey J, Beierle E, Kelly D, Crossman D
Sci Rep. 2017; 7(1):17787.
PMID: 29259192
PMC: 5736554.
DOI: 10.1038/s41598-017-17162-y.
AJAP1 expression modulates glioma cell motility and correlates with tumor growth and survival.
Di C, Mladkova N, Lin J, Fee B, Rivas M, Chunsheng K
Int J Oncol. 2017; 52(1):47-54.
PMID: 29115565
PMC: 5743336.
DOI: 10.3892/ijo.2017.4184.
Deregulated AJAP1/β-catenin/ZEB1 signaling promotes hepatocellular carcinoma carcinogenesis and metastasis.
Han J, Xie C, Pei T, Wang J, Lan Y, Huang K
Cell Death Dis. 2017; 8(4):e2736.
PMID: 28383563
PMC: 5477574.
DOI: 10.1038/cddis.2017.126.
Chromodomain-helicase-DNA binding protein 5, 7 and pronecrotic mixed lineage kinase domain-like protein serve as potential prognostic biomarkers in patients with resected pancreatic adenocarcinomas.
Seldon C, Colbert L, Hall W, Fisher S, Yu D, Landry J
World J Gastrointest Oncol. 2016; 8(4):358-65.
PMID: 27096031
PMC: 4824714.
DOI: 10.4251/wjgo.v8.i4.358.
Role of microRNAs in epigenetic silencing of the CHD5 tumor suppressor gene in neuroblastomas.
Naraparaju K, Kolla V, Zhuang T, Higashi M, Iyer R, Kolla S
Oncotarget. 2016; 7(13):15977-85.
PMID: 26895110
PMC: 4941291.
DOI: 10.18632/oncotarget.7434.
Retinoic acid-induced CHD5 upregulation and neuronal differentiation of neuroblastoma.
Higashi M, Kolla V, Iyer R, Naraparaju K, Zhuang T, Kolla S
Mol Cancer. 2015; 14:150.
PMID: 26245651
PMC: 4527355.
DOI: 10.1186/s12943-015-0425-y.
Elevated C1orf63 expression is correlated with CDK10 and predicts better outcome for advanced breast cancers: a retrospective study.
Hong C, Zhang F, You Y, Qiu W, Giuliano A, Cui X
BMC Cancer. 2015; 15:548.
PMID: 26209438
PMC: 4513615.
DOI: 10.1186/s12885-015-1569-2.